Quarterly report pursuant to Section 13 or 15(d)

Business Combination, Segment Allocation (Details)

v3.10.0.1
Business Combination, Segment Allocation (Details) - USD ($)
$ in Thousands
9 Months Ended
Aug. 31, 2018
Nov. 30, 2017
Goodwill $ 15,632 $ 10,684
CureCell [Member]    
Cash and cash equivalents 58  
Property and equipment, net 1,104  
Inventory 148  
Other assets 300  
Other Intangible assets 3,933  
Goodwill 3,950  
Total assets 9,493  
Deferred income from the company and others 1,945  
Deferred taxes 80  
Fair value of convertible loan from the company 892  
Non-controlling interests 299  
Other liabilities 1,487  
Total liabilities 4,703  
Total consideration transferred 4,790  
Fair value according of shares issued 1,853  
Acquisition date fair value of previously held equity interest $ 2,937